Research Paper: Treatment preferences of Australian patients with TRD
CaPPRe has published a peer reviewed research paper on treatment preferences of people living with Treatment-Resistant Depression (TRD).
Using discrete choice experiments (DCEs), this study examined treatment preferences among Australians with TRD, focusing on the specific treatment attributes that people value (such as effectiveness, risk of side effects and cost) and their relative importance. The risk-benefit trade-offs that characterise treatment choices were also examined.
The study highlights the importance of considering and discussing patient preferences to guide informed decisions regarding the value of new and existing medications for TRD and how they sit in the context of treatment plans. The paper can be accessed here